Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones12-21 05:43

DJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ inched 0.16% higher to $397.27 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.09% to 5,930.85 and the Dow Jones Industrial Average rising 1.18% to 42,840.26.

The stock's rise snapped a two-day losing streak.

Vertex Pharmaceuticals Inc. closed $122.61 short of its 52-week high ($519.88), which the company achieved on November 8th.

The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 2.37% to $175.58, Krystal Biotech Inc. (KRYS) rose 2.49% to $164.83, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 4.31% to $15.48.

Trading volume (6.1 M) eclipsed its 50-day average volume of 1.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 20, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 20, 2024 16:43 ET (21:43 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2493747403?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-21 05:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493747403","market":"hk","top_or_hot":-1,"title":"Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Vertex Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VRTX\">$(VRTX)$</a> inched 0.16% higher to $397.27 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index  rising 1.09% to 5,930.85 and the Dow Jones Industrial Average  rising 1.18% to 42,840.26. \n</p>\n<p>\n     The stock's rise snapped a two-day losing streak. \n</p>\n<p>\n     Vertex Pharmaceuticals Inc. closed $122.61 short of its 52-week high ($519.88), which the company achieved on November 8th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> rose 2.37% to $175.58, <a href=\"https://laohu8.com/S/KRYS\">Krystal Biotech Inc.</a> (KRYS) rose 2.49% to $164.83, and Arcturus <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Holdings Inc. <a href=\"https://laohu8.com/S/ARCT\">$(ARCT)$</a> rose 4.31% to $15.48. \n</p>\n<p>\n     Trading volume (6.1 M) eclipsed its 50-day average volume of 1.4 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 20, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 20, 2024 16:43 ET (21:43 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-21 05:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2493747403","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493747403","pubTimestamp":1734730980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Vertex Pharmaceuticals Inc.  inched 0.16% higher to $397.27 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.09% to 5,930.85 and the Dow Jones Industrial Average  rising 1.18% to 42,840.26.The stock's rise snapped a two-day losing streak.Vertex Pharmaceuticals Inc. closed $122.61 short of its 52-week high , which the company achieved on November 8th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  rose 2.37% to $175.58, Krystal Biotech Inc.  rose 2.49% to $164.83, and Arcturus Therapeutics Holdings Inc.  rose 4.31% to $15.48.Trading volume  eclipsed its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 20, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independen","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药","VERX":"Vertex, Inc."},"translate_title":"Vertex Pharmaceuticals Inc.股价周五上涨，但仍跑输大盘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERX":1,"VRTX":1},"content_text":"DJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ inched 0.16% higher to $397.27 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.09% to 5,930.85 and the Dow Jones Industrial Average  rising 1.18% to 42,840.26. \n\n\n     The stock's rise snapped a two-day losing streak. \n\n\n     Vertex Pharmaceuticals Inc. closed $122.61 short of its 52-week high ($519.88), which the company achieved on November 8th. \n\n\n     The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 2.37% to $175.58, Krystal Biotech Inc. (KRYS) rose 2.49% to $164.83, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 4.31% to $15.48. \n\n\n     Trading volume (6.1 M) eclipsed its 50-day average volume of 1.4 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 20, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 20, 2024 16:43 ET (21:43 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493747403"}